deferasirox

It is used to remove excess iron from the body (iron overload) in patients with beta thalassemia major, other forms of anemia, or thalassemia syndromes who may have accumulated too much iron due to frequent blood transfusions or increased iron absorption through diet.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: Abdi Farma GmbH

It is used to remove excess iron from the body (iron overload) in patients with beta thalassemia major who receive frequent transfusions, in patients with other forms of anemia, or in children aged 2 to 5 years when deferoxamine therapy is unsuitable or contraindicated. It is also used for patients aged 10 years and older with iron overload associated with thalassemia syndromes that do not require transfusions.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: ACCORD HEALTHCARE, S.L.U.

It is used to treat chronic iron overload due to frequent blood transfusions in patients with beta thalassemia major aged 6 years and older. It is also indicated for patients with other forms of anemia or thalassemia syndromes who do not receive transfusions, or for children between 2 and 5 years of age, when deferoxamine therapy is contraindicated or inadequate.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.

It is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta thalassemia major aged 6 years and older. It is also indicated for other patients with iron overload due to infrequent transfusions, other forms of anemia, or thalassemia syndromes, depending on age and specific conditions.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: GLENMARK ARZNEIMITTEL GMBH

It is used to treat chronic iron overload due to frequent blood transfusions in patients with beta thalassemia major (from 6 years of age and older). It is also indicated for patients with other forms of anemia or thalassemia syndromes who do not receive regular transfusions, when other therapies are unsuitable or contraindicated.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: MYLAN PHARMACEUTICALS LIMITED

It is used to remove excess iron from the body (iron overload) in patients with beta thalassemia major aged 6 years and older who receive frequent blood transfusions. It is also indicated for children aged 2 to 5 years or patients with other forms of anemia or thalassemia syndromes who do not receive transfusions, when deferoxamine therapy is contraindicated or inadequate.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: SANDOZ S.P.A.

It is used to treat excess iron in the body (iron overload) in patients with beta thalassemia major (from 6 years of age), in children aged 2 to 5 years with iron overload due to infrequent transfusions or in other forms of anemia, and in patients aged 10 years and older with thalassemia syndromes that do not require transfusions.

Form: tablets, dispersible

ATC: V03AC03

Manufacturer: SIGILLATA LIMITED

It is a medicinal product used to remove excess iron from the body (iron overload). It is prescribed to patients with beta thalassemia major (from 6 years of age and older) who receive frequent transfusions, or in other cases of anemia and thalassemia syndromes where standard therapy is unsuitable or contraindicated.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V.

It is used to remove excess iron from the body (iron overload) in patients with beta thalassemia major who receive frequent blood transfusions, or in patients with other forms of anemia and children between 2 and 5 years of age when deferoxamine therapy is inadequate or contraindicated. It is also indicated for patients aged 10 years and older with iron overload associated with thalassemia syndromes that do not require transfusions.

Form: tablets, film-coated

ATC: V03AC03

Manufacturer: ZENTIVA ITALIA S.R.L.

It is used to remove excess iron from the body (iron overload) in patients with beta thalassemia major, other forms of anemia, or thalassemia syndromes, often due to frequent blood transfusions.

Form: tablets, dispersible

ATC: V03AC03

Manufacturer: NOVARTIS EUROPHARM LIMITED